September 10, 1996Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

A New Class of Antihypertensive Therapy: Angiotensin II Receptor Antagonists

View Full Paper

Ask AI

Bookmark

Population

Patients with hypertension

Comparison

Angiotensin II receptor antagonists as… vs Angiotensin-converting enzyme inhibitors

Design

Review

Authors

MEMelissa L. EllisUniversity of Derby JPJ. Herbert PattersonUniversity of North Carolina at Chapel Hill

Discussion

Member takes

Implication

May support ARB use in ACEI-intolerant patients; leaves open whether more complete RAS blockade improves outcomes.

Structured PICO

Population

Patients with hypertension

Intervention

Angiotensin II receptor antagonists (e.g., losartan) as monotherapy or complementary therapy

Comparator

Angiotensin-converting enzyme inhibitors

Angiotensin II receptor antagonists represent a class of antihypertensive agents that may offer more complete renin-angiotensin system blockade and fewer side effects like cough compared to ACE inhibitors.

Cite This Study

Ellis et al. (1996) studied this question.

synapsesocial.com/papers/6a8332373b194ef92e582db2 https://doi.org/10.1002/j.1875-9114.1996.tb03001.x

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

A New Class of Antihypertensive Therapy: Angiotensin II Receptor Antagonists

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

A New Class of Antihypertensive Therapy: Angiotensin II Receptor Antagonists

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider